These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22285962)

  • 1. Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy.
    Shababi M; Habibi J; Ma L; Glascock JJ; Sowers JR; Lorson CL
    J Mol Cell Cardiol; 2012 May; 52(5):1074-82. PubMed ID: 22285962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac defects contribute to the pathology of spinal muscular atrophy models.
    Shababi M; Habibi J; Yang HT; Vale SM; Sewell WA; Lorson CL
    Hum Mol Genet; 2010 Oct; 19(20):4059-71. PubMed ID: 20696672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.
    Hua Y; Sahashi K; Rigo F; Hung G; Horev G; Bennett CF; Krainer AR
    Nature; 2011 Oct; 478(7367):123-6. PubMed ID: 21979052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.
    Dominguez E; Marais T; Chatauret N; Benkhelifa-Ziyyat S; Duque S; Ravassard P; Carcenac R; Astord S; Pereira de Moura A; Voit T; Barkats M
    Hum Mol Genet; 2011 Feb; 20(4):681-93. PubMed ID: 21118896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological Defects in Intestine in Severe Spinal Muscular Atrophy Mice Are Improved by Systemic Antisense Oligonucleotide Treatment.
    Sintusek P; Catapano F; Angkathunkayul N; Marrosu E; Parson SH; Morgan JE; Muntoni F; Zhou H
    PLoS One; 2016; 11(5):e0155032. PubMed ID: 27163330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of spinal muscular atrophy.
    Glascock JJ; Shababi M; Wetz MJ; Krogman MM; Lorson CL
    Biochem Biophys Res Commun; 2012 Jan; 417(1):376-81. PubMed ID: 22172949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy.
    Passini MA; Bu J; Richards AM; Treleaven CM; Sullivan JA; O'Riordan CR; Scaria A; Kells AP; Samaranch L; San Sebastian W; Federici T; Fiandaca MS; Boulis NM; Bankiewicz KS; Shihabuddin LS; Cheng SH
    Hum Gene Ther; 2014 Jul; 25(7):619-30. PubMed ID: 24617515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocytes influence the severity of spinal muscular atrophy.
    Rindt H; Feng Z; Mazzasette C; Glascock JJ; Valdivia D; Pyles N; Crawford TO; Swoboda KJ; Patitucci TN; Ebert AD; Sumner CJ; Ko CP; Lorson CL
    Hum Mol Genet; 2015 Jul; 24(14):4094-102. PubMed ID: 25911676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration.
    Arnold WD; Duque S; Iyer CC; Zaworski P; McGovern VL; Taylor SJ; von Herrmann KM; Kobayashi DT; Chen KS; Kolb SJ; Paushkin SV; Burghes AH
    PLoS One; 2016; 11(12):e0167077. PubMed ID: 27907033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery.
    Bevan AK; Hutchinson KR; Foust KD; Braun L; McGovern VL; Schmelzer L; Ward JG; Petruska JC; Lucchesi PA; Burghes AH; Kaspar BK
    Hum Mol Genet; 2010 Oct; 19(20):3895-905. PubMed ID: 20639395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the therapeutic window in a severe animal model of spinal muscular atrophy.
    Robbins KL; Glascock JJ; Osman EY; Miller MR; Lorson CL
    Hum Mol Genet; 2014 Sep; 23(17):4559-68. PubMed ID: 24722206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates.
    Meyer K; Ferraiuolo L; Schmelzer L; Braun L; McGovern V; Likhite S; Michels O; Govoni A; Fitzgerald J; Morales P; Foust KD; Mendell JR; Burghes AH; Kaspar BK
    Mol Ther; 2015 Mar; 23(3):477-87. PubMed ID: 25358252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Motor Neuron Support by SMA Astrocytes due to Diminished MCP1 Secretion.
    Martin JE; Nguyen TT; Grunseich C; Nofziger JH; Lee PR; Fields D; Fischbeck KH; Foran E
    J Neurosci; 2017 May; 37(21):5309-5318. PubMed ID: 28450545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.
    Passini MA; Bu J; Roskelley EM; Richards AM; Sardi SP; O'Riordan CR; Klinger KW; Shihabuddin LS; Cheng SH
    J Clin Invest; 2010 Apr; 120(4):1253-64. PubMed ID: 20234094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy.
    Ahmad S; Wang Y; Shaik GM; Burghes AH; Gangwani L
    Hum Mol Genet; 2012 Jun; 21(12):2745-58. PubMed ID: 22422766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV9-Mediated Expression of SMN Restricted to Neurons Does Not Rescue the Spinal Muscular Atrophy Phenotype in Mice.
    Besse A; Astord S; Marais T; Roda M; Giroux B; Lejeune FX; Relaix F; Smeriglio P; Barkats M; Biferi MG
    Mol Ther; 2020 Aug; 28(8):1887-1901. PubMed ID: 32470325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology.
    Bowerman M; Murray LM; Beauvais A; Pinheiro B; Kothary R
    Neuromuscul Disord; 2012 Mar; 22(3):263-76. PubMed ID: 22071333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
    Liu H; Shafey D; Moores JN; Kothary R
    J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAV9-mediated SMN gene therapy rescues cardiac desmin but not lamin A/C and elastin dysregulation in Smn2B/- spinal muscular atrophy mice.
    Brown SJ; Šoltić D; Synowsky SA; Shirran SL; Chilcott E; Shorrock HK; Gillingwater TH; Yáñez-Muñoz RJ; Schneider B; Bowerman M; Fuller HR
    Hum Mol Genet; 2023 Oct; 32(20):2950-2965. PubMed ID: 37498175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.